Page last updated: 2024-08-05 12:05:48

isochromanes

null

ChEBI ID: 38762

Members (6)

MemberDefinitionRole
6-hydroxymelleinAn isochromane that is mellein bearing an additional hydroxy substituent at the 6-position.6-hydroxymellein
6-methoxy-8-hydroxy-3-methyl-3,4-dihydroisocoumarinAn isochromane that is mellein bearing a methoxy substituent at position 6.6-methoxymellein
ochracinAn isochromane that is 3,4-dihydroisocoumarin bearing methyl and hydroxy substituents at positions 3 and 8 respectively.mellein
ochratoxin aA phenylalanine derivative resulting from the formal condensation of the amino group of L-phenylalanine with the carboxy group of (3R)-5-chloro-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carboxylic acid (ochratoxin alpha). It is among the most widely occurring food-contaminating mycotoxins, produced by Aspergillus ochraceus, Aspergillus carbonarius and Penicillium verrucosum.ochratoxin A
ochratoxin bA phenylalanine derivative resulting from the formal condensation of the amino group of L-phenylalanine with the carboxy group of (3R)-8-hydroxy-3-methyl-1-oxo-3,4-dihydro-1H-2-benzopyran-7-carboxylic acid. Ochratoxin B differs from the more naturally abundant ochratoxin A in the absence of the dihydroisocoumarin chlorine atom. It has cytotoxic effects on kidney and liver cells in vitro but only minor effects in vivo, due to its rapid metabolism and excretion. It inhibits cell proliferation of human liver HepG2 cells at doses as low as 1 mug/ ml but lacks the genotoxic activity of ochratoxin A, even at higher concentrations.ochratoxin B
ochratoxin cA phenylalanine derivative that is the ethyl ester of ochratoxin A.ochratoxin C

Research

Studies (3,080)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990206 (6.69)18.7374
1990's319 (10.36)18.2507
2000's818 (26.56)29.6817
2010's1,235 (40.10)24.3611
2020's502 (16.30)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials18 (0.55%)5.53%
Reviews226 (6.88%)6.00%
Case Studies6 (0.18%)4.05%
Observational0 (0.00%)0.25%
Other3,035 (92.39%)84.16%